• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Is your company still on...





Actually to be more specific upper management is on crack with their ridiculous insane unrealistic metrics. They have lost the definition of SALES. it is an utter joke out here.
 












That's the 2nd problem. You stand up and tell them the reality, they don't listen and Guess what your out. It is extremly painful . Looking but not much where I'm at.